Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients

Allergy, Asthma and Clinical Immunology

Volumn 7, Issue 1, 2011, Pages

  Pitt, Tracy ^a   Kalicinsky, Chrystyna ^a   Warrington, Richard ^a   Cisneros, Nestor ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN E; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; CANADA; CHILD; CONTROLLED STUDY; DRUG SAFETY; DRUG SCREENING; EGG ALLERGY; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATCH TEST; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; SENSITIZATION;

EID: 80053923150     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-7-3     Document Type: Review

References (9)

1. O'Riordan S, Barton M, Yau Y, Read S, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010, 182:39-44. 2802603, 19926677.
2. Tuite A, Greer A, Whelan M, Winter A, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, Fisman D. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ 2010, 182:131-136. 10.1503/cmaj.091807, 2817319, 19959592.
3. Zarychanski R, Stuart T, Kumar A, Doucette S, Elliot L, Ketter J, Plummer F. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010, 182:257-264. 2826467, 20093297.
4. Waibel K, Gomez R. Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines. J Allergy Clin Immunol 2010, 125:749-751. 10.1016/j.jaci.2009.12.015, 20060576.
5. The Canadian Society of Allergy and Clinical Immunology Statement: administration of H1N1 and seasonal influenza vaccine to egg allergic individuals. Accessed July 23, 2010, The Canadian Society of Allergy and Clinical Immunology., http://www.csaci.ca/include/files/CSACI_H1N1_Statement.pdf
6. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010, 182:1981-7. 10.1503/cmaj.100746, 3001504, 21059773.
7. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627.
8. James J, Zeiger R, Lester M, Fassano M, Gern J, Mansfield L, Schwartz H, Sampson H, Windom H, Machtinger S, Lensing S. Safe administration of influenza vaccine to patients with egg allergy. J Pediatrics 1998, 133:624-8.
9. Gagnon R, Primeau M, Des Roches A, Lemire C, Kafan R, Carr S, Ouakki M, Benoit M, De Serres B. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Immunol 2010, 126:317-23. 10.1016/j.jaci.2010.05.037, 20579720.